Minimal hepatic encephalopathy

Canadian Journal of Gastroenterology

Volumn 27, Issue 10, 2013, Pages 572-574

  Stinton, Laura M ^a   Jayakumar, Saumya ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hepatic encephalopathy; Minimal hepatic encephalopathy; Neurocognitive testing; Quality of life

Indexed keywords

LACTITOL; LACTULOSE; PREBIOTIC AGENT; PROBIOTIC AGENT; RIFAXIMIN;

CRITICAL FLICKER FUSION; DRUG EFFICACY; ENCEPHALAPP STROOP TEST; HEPATIC ENCEPHALOPATHY; HUMAN; LIFESTYLE MODIFICATION; LIVER TRANSPLANTATION; MEDICATION THERAPY MANAGEMENT; MINIMAL HEPATIC ENCEPHALOPATHY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SCREENING TEST;

HEPATIC ENCEPHALOPATHY; HUMANS; QUALITY OF LIFE;

EID: 84885651087     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/547670     Document Type: Review

References (35)

1. Poordad FF. The burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(Suppl 1):3-9.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21. (Pubitemid 34183979)
3. Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-5. (Pubitemid 29248991)
4. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004;19:253-67. (Pubitemid 39361187)
5. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-5. (Pubitemid 34188860)
6. Minguez B, Garcia-Pagan JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006;43:707-14.
7. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 2009;50:2014-21.
8. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37-41. (Pubitemid 33064035)
9. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9. (Pubitemid 28299984)
10. Dhiman RK, Kurmi R, Thumburu KK, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010;55:2381-90.
11. Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol 2010;16:181-7.
12. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: A pilot study evaluating driving performance. J Hepatol 1994;21:1023-8.
13. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995;10:239-48.
14. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45. (Pubitemid 38337653)
15. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: A vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903-9. (Pubitemid 47301540)
16. Bajaj JS, Saeian K, Schubert CM, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test. Hepatology 2009;50:1175-83.
17. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596-604. (Pubitemid 351280728)
18. Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis. Hepatology 2012;55:1164-71.
19. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 2007;45:833-4. (Pubitemid 46450641)
20. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: Diagnosis, clinical significance and recommendations. J Hepatol 2005;42 Suppl:S45-53. (Pubitemid 40364603)
21. Randolph C, Hilsabeck R, Kato A, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009;29:629-35.
22. Duarte-Rojo A, Estradas J, Hernandez-Ramos R, Ponce-de-Leon S, Cordoba J, Torre A. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci 2011;56:3014-23.
23. Romero-Gomez M. Critical flicker frequency: It is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol 2007;47:10-1. (Pubitemid 46817698)
24. Bajaj JS, Thacker LR, Heuman DM, et al. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology 2013; February 6 (E-pub ahead of print).
25. Canadian Medical Association. Determining Medical Fitness to Operate Motor Vehicles: CMA Driver's Guide, 7th edn. Ottawa: Canadian Medical Association, 2006.
26. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007;45:549-59. (Pubitemid 46450607)
27. Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008;20:506-11. (Pubitemid 351667890)
28. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441-9. (Pubitemid 38569067)
29. Shukla S, Shukla A, Mehboob S, Guha S. Meta-Analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011;33:662-71.
30. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362:1071-81.
31. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011;106:307-16.
32. Bajaj JS, Heuman DM, Wade JB, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011;140:478-87:e1.
33. Mattarozzi K, Stracciari A, Vignatelli L, D'Alessandro R, Morelli MC, Guarino M. Minimal hepatic encephalopathy: Longitudinal effects of liver transplantation. Arch Neurol 2004;61:242-7. (Pubitemid 38197558)
34. Mechtcheriakov S, Graziadei IW, Mattedi M, et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 2004;10:77-83. (Pubitemid 38885897)
35. Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation? Liver Transpl 2004;10:84-7. (Pubitemid 38885898)